Suchergebnisse - "2494G1JF75"

PubPharm (28)

1

Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women

enthalten in: HIV clinical trials | 2018

von Brites, C. | Nóbrega, I. | Luz, E. | +3

2

Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trials

enthalten in: HIV clinical trials | 2014

von Powderly, W. | Hill, A. | Moecklinghoff, C.

3

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART

enthalten in: HIV clinical trials | 2013

von Casado, J. | de Los Santos, I. | Del Palacio, M. | +4

4

Meta-analysis of the safety, tolerability, and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in HIV-1-infected women

enthalten in: HIV clinical trials | 2012

von Hermes, A. | Squires, K. | Fredrick, L. | +4

5

A pilot, prospective, open-label simplification study to evaluate the safety, efficacy, and pharmacokinetics of once-daily lopinavir-ritonavir monotherapy in HIV-HCV coinfected patients : the MONOCO study

enthalten in: HIV clinical trials | 2012

von Cooper, C. | la Porte, C. | Tossonian, H. | +3

6

Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects : the progress study, 48-week results

enthalten in: HIV clinical trials | 2011

von Reynes, J. | Lawal, A. | Pulido, F. | +6

7

Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression : results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study)

enthalten in: HIV clinical trials | 2009

von Nunes, E. | Santini de Oliveira, M. | Merçon, M. | +6

8

Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir

enthalten in: HIV clinical trials | 2009

von Rathbun, C. | Liedtke, M. | Blevins, S. | +4

9

Novel methodology for antiretroviral quantitation in the female genital tract

enthalten in: HIV clinical trials | 2009

von Bennetto-Hood, C. | Johnson, V. | King, J. | +2

10

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks

enthalten in: HIV clinical trials | 2009

von Pulido, F. | Estrada, V. | Baril, J. | +8